Cargando…

Lung Cancer Organoids: The Rough Path to Personalized Medicine

SIMPLE SUMMARY: Lung cancer is very difficult to cure, especially when it has spread to other parts of the body. One of the main reasons that delay the identification of effective therapies is the complexity of lung cancer cells, which can be very different among individual patients. Organoids are s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rossi, Rachele, De Angelis, Maria Laura, Xhelili, Eljona, Sette, Giovanni, Eramo, Adriana, De Maria, Ruggero, Cesta Incani, Ursula, Francescangeli, Federica, Zeuner, Ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367558/ https://www.ncbi.nlm.nih.gov/pubmed/35954367 http://dx.doi.org/10.3390/cancers14153703

Ejemplares similares

An Orthotopic Patient-Derived Xenograft (PDX) Model Allows the Analysis of Metastasis-Associated Features in Colorectal Cancer
por: De Angelis, Maria Laura, et al.
Publicado: (2022)

Repeated Exposure to Subinfectious Doses of SARS-CoV-2 May Promote T Cell Immunity and Protection against Severe COVID-19
por: De Angelis, Maria Laura, et al.
Publicado: (2021)

CRIPTO Is a Marker of Chemotherapy-Induced Stem Cell Expansion in Non-Small Cell Lung Cancer
por: Francescangeli, Federica, et al.
Publicado: (2022)

Dormancy, stemness, and therapy resistance: interconnected players in cancer evolution
por: Francescangeli, Federica, et al.
Publicado: (2023)

COVID-19–Induced Modifications in the Tumor Microenvironment: Do They Affect Cancer Reawakening and Metastatic Relapse?
por: Francescangeli, Federica, et al.
Publicado: (2020)

COVID-19: a potential driver of immune-mediated breast cancer recurrence?
por: Francescangeli, Federica, et al.
Publicado: (2020)

Dietary Factors in the Control of Gut Homeostasis, Intestinal Stem Cells, and Colorectal Cancer
por: Francescangeli, Federica, et al.
Publicado: (2019)

Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities
por: De Angelis, Maria Laura, et al.
Publicado: (2019)

Colorectal Cancer Stem Cells: An Overview of Evolving Methods and Concepts
por: De Angelis, Maria Laura, et al.
Publicado: (2021)

An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile
por: De Angelis, Maria Laura, et al.
Publicado: (2022)

Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases
por: Grassi, Ludovica, et al.
Publicado: (2019)

Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance
por: De Angelis, Maria Laura, et al.
Publicado: (2019)

A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells
por: Orienti, Isabella, et al.
Publicado: (2019)

Analysis of Dormancy-Associated Transcriptional Networks Reveals a Shared Quiescence Signature in Lung and Colorectal Cancer
por: Cuccu, Adriano, et al.
Publicado: (2022)

Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models
por: Del Curatolo, Anais, et al.
Publicado: (2018)

Theratyping cystic fibrosis in vitro in ALI culture and organoid models generated from patient-derived nasal epithelial conditionally reprogrammed stem cells
por: Sette, Giovanni, et al.
Publicado: (2021)

L1077P CFTR pathogenic variant function rescue by Elexacaftor–Tezacaftor–Ivacaftor in cystic fibrosis patient-derived air–liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients
por: Lo Cicero, Stefania, et al.
Publicado: (2023)

Correction to: L1077P CFTR pathogenic variant function rescue by Elexacaftor–Tezacaftor–Ivacaftor in cystic fbrosis patient-derived air–liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients
por: Lo Cicero, Stefania, et al.
Publicado: (2023)

A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumors
por: Orienti, Isabella, et al.
Publicado: (2019)

Sequential Isolation and Characterization of Single CTCs and Large CTC Clusters in Metastatic Colorectal Cancer Patients
por: Francescangeli, Federica, et al.
Publicado: (2021)

A course on rough paths: with an introduction to regularity structures
por: Friz, Peter K, et al.
Publicado: (2014)

Multidimensional Stochastic Processes as Rough Paths: Theory and Applications
por: Friz, Peter K, et al.
Publicado: (2010)

A course on rough paths: with an introduction to regularity structures
por: Friz, Peter K, et al.
Publicado: (2020)

PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer
por: Milella, Michele, et al.
Publicado: (2017)

A Different Exosome Secretion Pattern Characterizes Patient-Derived Colorectal Cancer Multicellular Spheroids and Their Mouse Xenografts
por: Relucenti, Michela, et al.
Publicado: (2022)

The Ultrastructural Analysis of Human Colorectal Cancer Stem Cell-Derived Spheroids and Their Mouse Xenograft Shows That the Same Cells Types Have Different Ratios
por: Relucenti, Michela, et al.
Publicado: (2021)

Person-Centered Kidney Education: The Path Forward
por: Ladin, Keren, et al.
Publicado: (2020)

Path-Following Control of Wheeled Planetary Exploration Robots Moving on Deformable Rough Terrain
por: Ding, Liang, et al.
Publicado: (2014)

Patient-derived organoids and high grade serous ovarian cancer: from disease modeling to personalized medicine
por: Nero, Camilla, et al.
Publicado: (2021)

Effects of shear stress path and roughness on shear creep behavior of marine clay-concrete interface
por: Yao, Wangjing, et al.
Publicado: (2023)

Prioritizing Gene Cascading Paths to Model Colorectal Cancer Through Engineered Organoids
por: Ping, Yanyan, et al.
Publicado: (2020)

Sarcoma Spheroids and Organoids—Promising Tools in the Era of Personalized Medicine
por: Colella, Gianluca, et al.
Publicado: (2018)

Renal cancer: new models and approach for personalizing therapy
por: di Martino, Simona, et al.
Publicado: (2018)

Current trends in perfusion strategies for neonates undergoing aortic arch repair: the rough path to the perfect idea
por: Arcieri, Luigi, et al.
Publicado: (2020)

Clinical challenges of short bowel syndrome and the path forward for organoid-based regenerative medicine()
por: Endo, Ryoma, et al.
Publicado: (2023)

Organoid technology for personalized pancreatic cancer therapy
por: Bengtsson, Axel, et al.
Publicado: (2021)

Personalized chordoma organoids for drug discovery studies
por: Al Shihabi, Ahmad, et al.
Publicado: (2022)

Tumor organoids for cancer research and personalized medicine
por: Yang, Hui, et al.
Publicado: (2022)

Advances of Patient-Derived Organoids in Personalized Radiotherapy
por: Wang, Yuenan, et al.
Publicado: (2022)

Development of glioblastoma organoids and their applications in personalized therapy
por: Xu, Can, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pf1vi42k1r1v52ea9l1me4858a